Fluoxetine - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs.

13 Sep 2009 OBJECTIVE: To evaluate efficacy of fluoxetine hydrochloride for treatment of compulsive disorders in dogs. DESIGN: Randomized, controlled clinical trial. ANIMALS: 63 dogs with compulsive disorders. PROCEDURES: The diagnosis was confirmed on the ... Read more...

Antidepressant medication use during breastfeeding.

30 Aug 2009 We performed an electronic search by using MEDLINE, PreMEDLINE, Current Contents, Biological Abstracts, and PsycINFO from June 2002 to December 2008 using the following terms: "antidepressant drugs", "antidepressive agents", "human milk", ... Read more...

Restraint, hunger, and disinhibition following treatment for binge-eating disorder.

30 Aug 2009 OBJECTIVE: To examine changes in total, flexible and rigid restraint, hunger, and disinhibition in obese individuals with Binge-Eating Disorder (BED), and assess whether these variables are associated with binge abstinence at post-treatment and ... Read more...

Latest indexed articles for 'Fluoxetine - Therapeutic use'

These are the very latest articles for this heading:

• Probable fluoxetine-induced carotidynia. 24 Sep 2009
• Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs. 13 Sep 2009
• Antidepressant medication use during breastfeeding. 30 Aug 2009
• Restraint, hunger, and disinhibition following treatment for binge-eating disorder. 30 Aug 2009
• Nasal bleeding associated with fluoxetine and risperidone interaction: a case report. 30 Aug 2009
• Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. 30 Aug 2009
• Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data. 30 Aug 2009
• The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. 30 Aug 2009
• Clinical messages from the Treatment for Adolescents With Depression Study (TADS). 30 Aug 2009
• Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. 20 Aug 2009
• [Preventing weight gain in smoking cessation: there is no miracle solution] 3 Aug 2009
• 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. 3 Aug 2009
• Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. 30 Jul 2009
• Prognostic and diagnostic potential of the structural neuroanatomy of depression. 25 Jul 2009
• Use of a selective serotonin reuptake inhibitor for treatment of episodes of hypertonia and kyphosis in a young adult Scottish Terrier. 13 Jul 2009
• Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial. 29 Jun 2009
• Adolescent depression: assessment and treatment. 29 Jun 2009
• Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function. 29 Jun 2009
• Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder. 19 Jun 2009
• Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. 15 Jun 2009

See a longer list of these articles.

Technical information about 'Fluoxetine'

Definition: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.

Chemical name: Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-

Registry Number: 54910-89-3

Descriptor UI: D005473

Alternative terms: Fluoxetine; N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine; Fluoxetin; Sarafem; Prozac; Fluoxetine Hydrochloride; Lilly-110140; Lilly 110140; Lilly110140;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Serotonin Uptake Inhibitors; Antidepressive Agents, Second-Generation;

Tree Number: D02.092.831.280;

Online Note: use FLUOXETINE to search FLUOXETIN 1979-89

History Note: 90(79); was FLUOXETIN see under PROPYLAMINES 1979-88; was FLUOXETIN 1989